Search Orphan Drug Designations and Approvals
-
Generic Name: | mogamulizumab |
---|---|
Date Designated: | 07/14/2011 |
Orphan Designation: | Treatment of adult T-cell leukemia/lymphoma (ATLL). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Kyowa Kirin Pharmaceutical Development, Inc. 212 Carnegie Center Suite 101 Princeton, New Jersey 08540 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-